SIRT3 and head and neck cancer: Because radiation is the primary treatment modality in head and neck cancer, and cisplatin is 1 of the first chemotherapeutic drugs used to treat OSCC,26 we investigated whether SIRT3 down-regulation with siRNA enhances the sensitivity of OSCC cells to radiation and cisplatin.